Bertie
search
auto_awesomeActioninventory_2Consultant review
Action 2 · Task 248 · Group 12

Map the Non-Dilutive Grant Transition Architecture

The founder isolates the specific grant mechanisms that will fund pre-spinout de-risking without compromising commercial equity structures. This requires auditing existing research funding terms for background intellectual property restrictions, background ownership, and freedom to operate. The founder maps out how follow-on non-dilutive grants bridge the gap between academic research and commercial readiness.

Objective

This action maps the precise funding architecture required to advance the technology using non-dilutive capital before taking private investment. It ensures the parent task creates a legally sound, non-dilutive pathway that preserves equity value and prevents premature institutional encumbrance.

What's expected from the founder

A detailed grant audit matrix mapping all past, current, and pipeline grants against the core intellectual property stack. The founder must produce written confirmation of background IP boundaries and an explicit strategy for utilising targeted translational funding calls.

psychologyBertie consultant stress-test

Five questions an expert would ask when reviewing your output

Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.

  1. 1

    How do the terms of your current grant impact the commercial spinout's freedom to exploit the generated foreground IP?

  2. 2

    What mechanisms are in place to ensure academic researchers on the grant do not inadvertently publish patentable IP before filing?

  3. 3

    Why is this specific grant pathway superior to accelerating private equity investment at this stage?

  4. 4

    How have you accounted for state aid or Subsidy Control regulations when utilising university facilities for commercial de-risking?

  5. 5

    What evidence proves that the funding body's deliverables align directly with commercial value drivers rather than purely academic publications?